Use filters to refine the search results.
Results 1-7 of 7 (Search time: 0.001 seconds).
|2006||Cost estimates of primary health care activities for remote Aboriginal communities in the Northern Territory||Zhao, Yuejen; Hanssens, Peter; Byron, Peter; Guthridge, Steve||Report||Aboriginal people; Metabolic diseases; Health services; Remote areas; Costs and cost analysis; Chronic disease; Primary health care; Antenatal care; Health Economics|
|2014||Injuries in the Northern Territory, 1997-2011||Foley, Margaret; Zhao, Yuejen; You, Jiqiong; Skov, Steven||Report||Statistics; Public health; Injury surveillance; Hospitalisation; Mortality; Health Economics|
|Mar-2015||Renal Replacement Therapy Demand Study, Northern Territory, 2001 to 2022||You, Jiqiong; Lawton, Paul D; Zhao, Yuejen; Poppe, Susan; Cameron, Nicole; Guthridge, Steve||Technical Report||Statistics; End stage kidney diseases; Renal replacement therapy; Kidney diseases; Renal dialysis; Mortality; Strategy; Disease management; Health Economics|
|2005||Medicare and Pharmaceutical Benefits Scheme usage patterns in the Northern Territory, 1993-94 to 2003-04||Byron, Peter; Zhao, Yuejen; Guthridge, Steve; Brailsford, Roger; Stacey, Fred; Parkinson, Judy||Book||Pharmaceutical benefits; Medicare; Health insurance; Utilisation; Health services; Expenditures; Statistics; Health Economics|
|2010||Health workforce modelling, Northern Territory, 2006-2022||Malyon, Rosalyn; Zhao, Yuejen; Guthridge, Steve||Technical Report||Doctors; Nurses; Models; Workforce; Evaluation; Health Economics|
|2009||Burden of disease and injury in the Northern Territory, 1999-2003||Zhao, Yuejen; You, Jiqiong; Guthridge, Steve||Technical Report||Cost of illness; Health status indicators; Injuries; Risk factors; Aboriginal people; Statistics; Health and illness; Health Economics|
|2010||Medicare benefits schedule and pharmaceutical benefits scheme utilisation in the Northern Territory, 1993-94 to 2008-09||Malyon, Rosalyn; Zhao, Yuejen; Guthridge, Steve||Dataset||Statistics; Pharmaceutical benefits; Medicare; Utilisation; State medicine; Costs and cost analysis; Primary health care; Prescribed drugs; Health Economics|